-
1
المؤلفون: Hai-Jun Wen, Pei Lin, Gong-Xun Zhong, Zhi-Chao Xu, Lei Shuai, Zhi-Yuan Wen, Chong Wang, Xue Cao, Wen-Bin He, Jing Feng, Qi-Chun Cai, Hua-Juan Ma, Si-Jin Wu, Guo-Dong Wang, Xue-Mei Lyu, Feng-Liang Liu, Yong-Tang Zheng, Hui Zeng, Xiong-Lei He, Hualan Chen, Fu-Jie Zhang, Chung-I Wu
مصطلحات موضوعية: Drug, Clinical trial, 2019-20 coronavirus outbreak, Coronavirus disease 2019 (COVID-19), business.industry, media_common.quotation_subject, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), otorhinolaryngologic diseases, Harringtonine, Medicine, Bioinformatics, business, media_common
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1d5978a040023e42cdd80a1340382afd
https://doi.org/10.1101/2021.04.16.440104